Background: This study examines the diagnosis of malaria and pattern of prescription of antimalarial drugs in the most vulnerable age group (the under 5 children) in the study environment in order to identify the possible shortcomings and suggest solutions so as to improve the treatment outcome in future. Methods: The hospital records of 430 children with malaria infection admitted for treatment in a chosen tertiary health facility between January to December 2005 were selected for study. Forty-eight case records were excluded due to incomplete information. Data on demographic, clinical features of disease, diagnostic procedures, drug administration and the treatment out come were collected from the patients' records. Results: Analysis of the data revealed that more male (213) than female (169) children were admitted for malaria treatment: Fever with convulsion (55.8%) was the commonest presenting symptoms, and anemia was the most frequent complications of malaria recorded. Chloroquine was found to be the most prescribed antimalarial agent and overall antemisinin-based drug was prescribed either as a first or second line treatment in only 18.2% of the cases. The death rate recorded was 16%. Conclusion: The pattern of antimalarial drugs prescription in the study center in most cases did not meet the recommended guidelines. The prescriptions were predominantly chloroquine, instead of artemisinin based. The death rate was comparatively high. Measures to raise the level of awareness among the practitioners on the current National policy on malaria treatment through seminars and workshops were suggested.

No abstract

No abstract

Malaria is a major global health problem with the greatest burden in sub-Saharan Africa (sSA). Unfortunately, Nigeria accounts for 25 percent of the world’s malaria burden and it accounts for more deaths than HIV/AIDS. The causative agent of malaria is plasmodium species. This paper reviews the current approaches to inhibiting plasmodium transmission, and the phyto active compound currently in use in the sSA (particularly in Nigeria) with the goal to ameliorate the high incidence of malaria and to correlating it with recent progress and scientific understanding. Using search engines, several databases including Google scholar, Pub Med, Academic Resource Index, Scopus, etcetera, were utilized to source for relevant publications and literatures. The complex life cycle of the Plasmodium species (causative agent of malaria) gives room for measures that can disrupt its completion. Several methods are currently being tested and experimented on to disrupt the parasite transmission. The disruption of a cell surface transport protein, Feline Leukemia Virus subgroup C Receptor (FLVCR) that pumps heme out of the cell; Gene silencing-techniques used to reduce the levels of FLVCR in the mosquito gut; Prevention of the interaction between the plasmodium TRAP and the Anopheles Saglin protein, which aid the malaria parasite invasion of the mosquito salivary gland; Prevention of the Interaction of Surface Enolase and Plasminogen of Mammalian Blood, disrupting an important role in ookinete invasion of the mosquito midgut; the use of Plants with antimicrobial peptides(cyclotide), that possess structural similarities to SM1 peptide, an inhibitor of plasmodium TRAP-saglin binding;and Use of Phyto-Active Compounds to Block Plasmodium Transmission. These approaches are novel methods in the control and transmission of plasmodium species/malaria. Chemically, phytochemicals with structural similarities to artemisinin, (asesquiteterpene lactone containing an unusual peroxide bridge) is thought of to be present in certain plants with antimalarial and other medicinal value.

Background The aqueous methanolic extract of Andira inermis(A. inermis) stem bark was screened for phytochemical constituents, antioxidant activity, acute oral toxicity, and preliminary prophylactic normoglycaemic test and effect on Oral Glucose Tolerance in albino rats. Methods Andira inermis was double macerated and extracted with 80% methanol. Phytochemical analysis and acute toxicity were performed using standard methods. The extract was screened for in vitro antioxidant activity using Ferric Reducing/Antioxidant Power (FRAP) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging spectrophotometric assays. Prophylactic control of glucose was evaluated in normoglycaemic and glucose-challenged albino rats. Graded test doses (100–400 mg/kg body weight) of the extract were used in the investigation. The effects observed were compared with that of glibenclamide (0.2 mg/kg) and distilled water control groups. Results The stem bark extract of A. inermis was found to contain saponins, terpenes, tannins, steroids, flavanoids, anthraquinones, carbohydrates and alkaloids. The extract was found to have a significant in vitro antioxidant activity in both methods. The oral acute toxicity study showed the extract had LD50 greater than 5000 mg/kg. The extract significantly (p ≤ 0.05) reduced blood glucose levels in normoglycaemic animal model (the control group seen to have − 5.6(− 8.7%) poor glucose handling; and the glibenclamide& extract treatment group (100 mg/kg) to positively reduce blood glucose 14.8(26.8%) & 16.4(25.9%) respectively). The glucose challenged test, from the 1st hour, showed − 57.4(− 89.4%),-26.8(− 33.8%),-23.8(− 26.3%),-12.8(− 13.9%) and − 9.8(− 10.4%) for the vehicle control, glibenclamide (positive control), and the 100, 200 & 400 mg/kg extract treatment groups respectively. The extract showed mild hypoglycemic effect in the results recorded, up to the 4th hour. Conclusion The results of this study elucidated that the aqueous methanolic extract of Andira inermis stem bark possessed potent antioxidant phyto-constituents with potential hypoglycaemic effects that could be explored for therapeutic use worldwide following isolation and characterization of the bioactive principles. And the results also authenticate the folklore use of the plant.

No abstract

The aqueous methanolic Andira inermis stem bark extract was screened in evaluation of its potential for its toxic effect in a 28 days study using the oral route only. The sub acute study was carried out in Wistar rats divided into 4 groups of 5 rats each; control group (a) received distilled water while the aqueous methanolic Andira inermis stem bark extract treatment groups (b), (c), and (d), received 100, 200, and 400 mg/kg of the extract respectively, for a period of 28 days, with their intake of feeds, water and signs of abnormality observed. At the end of the sub acute study, the rats were anaesthetized with chloroform and blood collected by cardiac puncture for biochemical and haematological evaluation. And the visceral organs (liver, kidneys, lungs, heart and spleen) excised for weighing and patho-morphological examination. The aqueous methanolic Andira inermis stem bark extract was found to; reduce the intake of water weekly, drop intake of feeds; significantly increased the red blood cell count (RBC), the haemoglobin concentration (HB), as well as the pack cell volume (PCV). The renal indices, showed the electrolytes sodium and chloride of the treatment groups (b, c and d) to be significantly different from the control. Urea was noticed to have reduce significantly and creatinine insignificantly. The organs weights across the Andira inermis treatment groups were noticed to be insignificantly (P › 0.05) different from the control for all the organs sampled (Lungs, Liver, Heart and Spleen) except for the kidney (organ weight which was noticed to have increased significantly). The patho-morphologies of the organs showed the heart to be normal, the kidney was normal in the control and the other treatment groups 100 mg 400 mg and 200 mg but a rat (an outlier) in one of the 200 mg group was noticed with tubular necrosis; the liver indicated a non concentration-dependent hepatitis while the lungs and the spleen presented an infective process.  It was concluded that, the aqueous methanolic extract of Andira inermis is a safe medicinal plant with the capacity to; raise red blood cell count (RBC), haemoglobin concentration (HB) as well as the pack cell volume (PCV); proffers a nephro- protective property; shrunken spleen; have a hepato-protective property and as well was non toxic to the heart and lungs. These findings warrants further pharmacognostic efficacy experimental research to harness the array of benefits of Andira inermis as discovered in this study.

The oral toxicity profile of the crude aqueous stem bark extract of Pausinystalia yohimbe was studied in adult albino rats. The Up and Down method (AOT425statPgm version 1.0) for acute oral toxicity was carried out using a starting dose of 175 mg/kg body weight via the oral route. For the sub chronic study, 40 male albino rats weighing between 150-200 g, were grouped into three treatment groups and a control group with 10 rats in each group. A repeat dose oral toxicity study was conducted by daily oral dosing of 600 mg/kg body weight, 150 mg/kg body weight of extract dissolved in 1ml of 0.9% saline to groups 1 and 2, respectively and 30% powdered stem bark mixed with 70% rat chow (w/w) to group 3 and 1ml of 0.9% saline was administered to rats in the control group for 28 days. On day 29, blood samples for bioassay were collected by cardiac puncture under diethyl ether anesthesia. The LD50 estimate of the extract was calculated to be greater than 2000mg/kg body weight/oral route. The extract did not cause any significant difference in the body weight of the rats. Platelet count and White Blood Cell count (WBC) were significantly elevated across the treatment groups p<0.05. Total bilirubin was significantly higher p<0.05 in the 600 and 150mg treatment groups, while conjugated bilirubin was significantly higher in the 600 mg treatment group. Total protein was significantly lower p<0.05 in the 600mg treatment group. Aspartate Transaminase was significantly higher in all the treatment groups, while Alkaline phosphatase was significantly higher in the 600 and 150mg treatment groups, p<0.05, respectively. Alanine transaminase was significantly higher in 600 mg treatment group. Na + was elevated significantly, p<0.05. These results suggest incipient toxicity of the extract and indicate need for morphometric toxicity study.